Items where Funder is Amgen Ltd.

The University of Leeds

Sjoquist, KM, Renfro, LA, Simes, RJ et al. (31 more authors) (2017) Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram Project. Journal of the National Cancer Institute, 10 (6). djx253. ISSN 0027-8874

Hoorn, ST, Sommeijer, DW, Elliot, F et al. (12 more authors) (2021) Molecular subtype-specific efficacy of anti-EGFR therapy in colorectal cancer is dependent on the chemotherapy backbone. British Journal of Cancer. ISSN 0007-0920

Yin, J, Cohen, R, Jin, Z et al. (23 more authors) (2021) Prognostic and Predictive Impact of Primary Tumor Sidedness for Previously Untreated Advanced Colorectal Cancer. Journal of the National Cancer Institute. ISSN 0027-8874

Yin, J, Cohen, R, Jin, Z et al. (16 more authors) (2020) Prognostic and predictive impact of primary tumor sidedness in first-line trials for advanced colorectal cancer: An analysis of 7,828 patients in the ARCAD database. In: 2020 Gastrointestinal Cancers Symposium, 23-25 Jan 2020, San Francisco, California.

Seligmann, JF, Hatch, AJ, Richman, SD orcid.org/0000-0003-3993-5041 et al. (8 more authors) (2018) Association of Tumor HER3 Messenger RNA Expression With Panitumumab Efficacy in Advanced Colorectal Cancer. JAMA Oncology, 4 (4). pp. 564-568. ISSN 2374-2437